156 related articles for article (PubMed ID: 29787563)
21. Transcriptional analysis of aggressiveness and heterogeneity across grades of astrocytomas.
Wang C; Funk CC; Eddy JA; Price ND
PLoS One; 2013; 8(10):e76694. PubMed ID: 24146911
[TBL] [Abstract][Full Text] [Related]
22. Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.
Henriquez NV; Forshew T; Tatevossian R; Ellis M; Richard-Loendt A; Rogers H; Jacques TS; Reitboeck PG; Pearce K; Sheer D; Grundy RG; Brandner S
Cancer Res; 2013 Sep; 73(18):5834-44. PubMed ID: 23887970
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
24. Deconvolution and network analysis of IDH-mutant lower grade glioma predict recurrence and indicate therapeutic targets.
Li G; Jiang Y; Lyu X; Cai Y; Zhang M; Wang Z; Li G; Qiao Q
Epigenomics; 2019 Aug; 11(11):1323-1333. PubMed ID: 31272213
[No Abstract] [Full Text] [Related]
25. Molecular profiles for insular low-grade gliomas with putamen involvement.
Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L
J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911
[TBL] [Abstract][Full Text] [Related]
26. A systemic insight into astrocytoma biology across different grades.
Chakraborty S; Ghosh Z
J Cell Physiol; 2019 Apr; 234(4):4243-4255. PubMed ID: 30146735
[TBL] [Abstract][Full Text] [Related]
27. Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells.
Du C; Pan P; Jiang Y; Zhang Q; Bao J; Liu C
World J Surg Oncol; 2016 Oct; 14(1):258. PubMed ID: 27716259
[TBL] [Abstract][Full Text] [Related]
28. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of microRNA-210 in gliomas of variable cell origin and correlation between increased expression levels and disease progression in astrocytic tumours.
Lai N; Zhu H; Chen Y; Zhang S; Zhao X; Lin Y
Folia Neuropathol; 2014; 52(1):79-85. PubMed ID: 24729345
[TBL] [Abstract][Full Text] [Related]
30. Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.
Wu X; Feng F; Yang C; Zhang M; Cheng Y; Zhao Y; Wang Y; Che F; Zhang J; Heng X
J Mol Neurosci; 2019 Dec; 69(4):527-537. PubMed ID: 31377983
[TBL] [Abstract][Full Text] [Related]
31. Regulatory landscape and clinical implication of MBD3 in human malignant glioma.
Cui Y; Li J; Weng L; Wirbisky SE; Freeman JL; Liu J; Liu Q; Yuan X; Irudayaraj J
Oncotarget; 2016 Dec; 7(49):81698-81714. PubMed ID: 27835581
[TBL] [Abstract][Full Text] [Related]
32. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
Ivliev AE; 't Hoen PA; Sergeeva MG
Cancer Res; 2010 Dec; 70(24):10060-70. PubMed ID: 21159630
[TBL] [Abstract][Full Text] [Related]
33. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
34. Identification of the potential biomarkers in patients with glioma: a weighted gene co-expression network analysis.
Chen TY; Liu Y; Chen L; Luo J; Zhang C; Shen XF
Carcinogenesis; 2020 Jul; 41(6):743-750. PubMed ID: 31761927
[TBL] [Abstract][Full Text] [Related]
35. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
Zhang C; Li J; Wang H; Song SW
Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
[TBL] [Abstract][Full Text] [Related]
36. Regulation of IL-8 gene expression in gliomas by microRNA miR-93.
Fabbri E; Brognara E; Montagner G; Ghimenton C; Eccher A; Cantù C; Khalil S; Bezzerri V; Provezza L; Bianchi N; Finotti A; Borgatti M; Moretto G; Chilosi M; Cabrini G; Gambari R
BMC Cancer; 2015 Oct; 15():661. PubMed ID: 26449498
[TBL] [Abstract][Full Text] [Related]
37. RNA-binding Protein UNR Promotes Glioma Cell Migration and Regulates the Expression of Ribosomal Protein L9.
Tian NY; Qi YJ; Hu Y; Yin B; Yuan JG; Qiang BQ; Peng XZ; Han W
Chin Med Sci J; 2018 Sep; 33(3):143-151. PubMed ID: 30266104
[TBL] [Abstract][Full Text] [Related]
38. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
Vizcaíno MA; Shah S; Eberhart CG; Rodriguez FJ
Hum Pathol; 2015 Sep; 46(9):1323-30. PubMed ID: 26190195
[TBL] [Abstract][Full Text] [Related]
40. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
